Wednesday, July 22, 2026 at 2:00 pm ET <br><br> In this panel, benefits and healthcare leaders will explore how employers can evaluate women's and family health benefits through the lens of clinical outcomes, total cost of care, and workforce impact, while identifying what distinguishes truly integrated, outcomes-driven solutions from traditional coverage-focused offerings.
About 6% of the plan participants were using the weight-loss drugs. Covering GLP-1s, for an enrollee who took the drug, cost the plans surveyed an average of $7,400 per year.
